The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
sorafenib tosylate
The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | BAY 43-9006 BAY 43-9006 Tosylate Salt | |
| |||
| US brand name: | | Nexavar | |
| |||
| Abbreviation: | | SFN | |
| |||
| Code name: | | BAY 54-9085 | |
| |||
| Chemical structures: | | 2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3- trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl- 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate tosylate | |
| |||
